Sven Koch

Sven Koch is an accomplished immunologist with extensive experience in both academic and industry settings. Currently serving as Director of Immuno-Monitoring at CureVac since September 2020, Koch has held various significant roles including Associate Director of Immuno-Monitoring and Head of Biomarkers & Immunoanalysis at the same company. Prior experiences include Head of Translational Research at CatalYm GmbH and Laboratory Head Clinical Bioanalytics at Sandoz. Koch's research focuses on the identification of novel biomarkers and immune responses in clinical trials involving mRNA-based vaccines and therapeutics. With a PhD in Biology/Immunology from the University of Tübingen and a strong background in experimental immunology, Koch has contributed to the field through pivotal research and leadership roles.